Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
45 Leser
Artikel bewerten:
(0)

Global Endovascular Aneurysm Repair (EVAR) Market Report: 2016 Report Featuring Lombard Medical (Aorfix), Medtronic Inc. (Endurant) & TriVascular (Ovation Xi)

DUBLIN, January 20, 2016 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/nnt4xc/global) has announced the addition of the"Global Endovascular Aneurysm Repair (EVAR) Market Report: 2016" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report assesses the global EVAR market in terms of both market volume and market value on the global and regional level. The increasing competition in the EVAR industry has been analyzed on a variety of factors: revenue, surgical outcomes, postoperative procedures and complications. The top three companies having a vicious competition with each other and dominating the EVAR industry are- Medtronic, TriVascular and Lombard Medical. These players are being profiled in the report along with their key financials and strategies for growth.

Endovascular aneurysm repair (EVAR) is a minimally invasive alternative to major open surgery for the repair of AAA's that results in reduced recovery times and potentially improved survival rates. It is a type of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). Endovascular procedures aim to reduce the morbidity and mortality of treating arterial disease in a patient population that is increasingly older and less fit than when major open repairs were developed and popularized.

Growing numbers of geriatric population and associated expenditure for health care, steadily increasing cases of AAA screening worldwide are likely to fuel growth over the coming years. Postoperative complications like Endoleaks and migration is the biggest challenge faced by the industry. Also the growing number of regulations posed by regulatory authorities like FDA restricts the industry players. Some of the trends impacting the market include ongoing clinical studies, growing use of percutaneous EVAR, preferences for various AAA repair methods, and technological developments.

Key Topics Covered:

1. Abdominal Aortic Aneurysm (AAA)

2. Endovascular Aneurysm Repair (EVAR)

3. Market Dynamics

4. Competitive Landscape

5. Company Profiles

- Lombard Medical (Aorfix)
- Medtronic Inc. (Endurant)
- TriVascular (Ovation Xi)

For more information visithttp://www.researchandmarkets.com/research/nnt4xc/global

About Research and Markets:

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.